James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)

James E. Flynn, the manager of Deerfield Management, is still bullish on Streamline Health Solutions Inc. (NASDAQ:STRM). According to a recent filing with the Securities and Exchange Commission, Deerfield Management currently holds 1.14 million shares, up from the 325,000 shares reported in its latest 13F filing. The fund’s current position accounts for 6.56% of the company’s common shares. Flynn initiated the position in Streamline Health Solutions during the fourth quarter of 2013.

Streamline Health Solutions Inc. (NASDAQ:STRM)

James Dondero of Highland Capital Management is also fond of the company, having initiated a position during the last three months of 2013. In its latest 13F filing, Highland Capital has reported ownership of approximately 147,100 shares valued at $1.02 million. Moreover, Richard S. Meisenberg has significantly increased his investment in Streamline Health Solutions Inc. (NASDAQ:STRM). His fund, ACK Asset Management, currently holds 642,700 shares reportedly worth $4.48 million.

Streamline Health Solutions Inc. (NASDAQ:STRM) is a provider of business analytic solutions for healthcare organizations and is active mainly in North America. The company has a market cap of $89.05 million and does not pay a dividend. Following a significant surge from April 2012, the stock has peaked at $8.5 per share on November 1, 2013 and has been in a downtrend ever since. For the three months ending October 31, 2013, Streamline Health Solutions posted revenues of $6.73 million and a loss per share of $0.5. Analysts expect $7.05 million in revenues and a loss of $0.11 per share.

Flynn has increased his fund’s investments in several other companies recently, one of them being Alphatec Holdings Inc (NASDAQ:ATEC). Deerfield holds 14.2 million shares or 9.98% of the total number of shares outstanding. In another move, Flynn has roughly tripled hid fund’s position in OvaScience Inc (NASDAQ:OVAS) to 1.8 million shares, which accounts for 7.6% of the company’s common shares.

Disclosure: none.

Recommended reading:

James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)

Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)

Deerfield Management Further Raises Its Position in Auspex Pharmaceuticals Inc (ASPX)